Astrocyte SMN Restoration and Forskolin Treatment Improve SMA Synaptic Pathology.
OBJECTIVE Early phenotypic presentation of central afferent synapse dysfunction within patients with spinal muscular atrophy (SMA) represents a key target for therapeutic development; however, the underlying disease mechanisms remain unresolved. By further investigating motor neuron synapse and peri-synaptic astrocyte...